Nitroglycerin Disposition in Human Blood

Overview

Journal Eur J Clin Pharmacol

Specialty Pharmacology

Date 1985 Jan 1

PMID 3935462

Citations 10

Authors

P A Cossum

M S Roberts

Affiliations

Soon will be listed here.

Abstract

The disposition in vitro of nitroglycerin (GTN) and its metabolites in erythrocyte suspensions, plasma and blood has been studied using labelled (3H) and unlabelled GTN and GTN metabolites separated by HPLC. GTN was rapidly metabolised (t1/2 3 min) to dinitro-metabolites and subsequently to the mononitronitrates in erythrocyte suspensions containing a therapeutic concentration of GTN (0.8-10 ng/ml). The metabolism of GTN and its dinitro-metabolites was concentration dependent. GTN and its dinitro-metabolites were plasma protein bound (11-60%). They had an apparent erythrocyte-plasma partition coefficient in the range 0.6 to 0.9. The metabolism of GTN by erythrocytes was partially inhibited by the presence of the dinitro-metabolites of GTN. The metabolism of GTN in blood samples collected from patients could be stopped by adding the collected blood to chilled tubes containing the enzyme inhibitor iodoacetamide.

Citing Articles

Drug structure-transport relationships.

Roberts M J Pharmacokinet Pharmacodyn. 2010; 37(6):541-73.

PMID: 21107662 PMC: 3005109. DOI: 10.1007/s10928-010-9174-0.

Clinical pharmacokinetics and pharmacodynamics of glyceryl trinitrate and its metabolites.

Hashimoto S, Kobayashi A Clin Pharmacokinet. 2003; 42(3):205-21.

PMID: 12603173 DOI: 10.2165/00003088-200342030-00001.

Nitroglycerin dinitrate metabolites do not affect the pharmacokinetics and pharmacodynamics of nitroglycerin in the dog: a preliminary report.

Lee F, Hu J, Metzler C, Benet L J Pharmacokinet Biopharm. 1993; 21(2):163-73.

PMID: 8229678 DOI: 10.1007/BF01059768.

Pharmacokinetics and pharmacodynamics of nitroglycerin and its dinitrate metabolites in conscious dogs: intravenous infusion studies.

Lee F, Salmonson T, Benet L J Pharmacokinet Biopharm. 1993; 21(5):533-50.

PMID: 8145130 DOI: 10.1007/BF01059113.

A modified product inhibition model describes the nonlinear pharmacokinetics of nicorandil in rats.

Bachert E, Li Z, Zhao L, Chung S, Fung H Pharm Res. 1994; 11(8):1190-8.

PMID: 7971723 DOI: 10.1023/a:1018953319288.

References

Pedersen P . Curve fitting and modeling in pharmacokinetics and some practical experiences with NONLIN and a new program FUNFIT. J Pharmacokinet Biopharm. 1977; 5(5):513-31. DOI: 10.1007/BF01061732. View

Lang S, Johnson Jr E, NEEDLEMAN P . Metabolism of and vascular responses to glyceryl trinitrate in the eviscerated rat. Biochem Pharmacol. 1972; 21(3):422-4. DOI: 10.1016/0006-2952(72)90356-5. View

TAYLOR I, Ioannides C, Turner J, Koenigsberger R, Parke D . Micro determination of glyceryl trinitrate in biological fluids; effect of deuteration of glyceryl trinitrate on its pharmacokinetic properties. J Pharm Pharmacol. 1981; 33(4):244-6. DOI: 10.1111/j.2042-7158.1981.tb13768.x. View

SOKOLOSKI T, Wu C, Wu L, BURKMAN A . Interaction of nitroglycerin with human blood components. J Pharm Sci. 1983; 72(4):335-8. DOI: 10.1002/jps.2600720403. View

Franciosa J, Blank R, Cohn J . Nitrate effects on cardiac output and left ventricular outflow resistance in chronic congestive heart failure. Am J Med. 1978; 64(2):207-13. DOI: 10.1016/0002-9343(78)90047-5. View

McNiff E, Yacobi A, GOLDEN L, Goldfarb A, Fung H . Nitroglycerin pharmacokinetics after intravenous infusion in normal subjects. J Pharm Sci. 1981; 70(9):1054-8. DOI: 10.1002/jps.2600700923. View

Flaherty J, Reid P, Kelly D, Taylor D, WEISFELDT M, Pitt B . Intravenous nitroglycerin in acute myocardial infarction. Circulation. 1975; 51(1):132-9. DOI: 10.1161/01.cir.51.1.132. View

Yap P, McNiff E, Fung H . Improved GLC determination of plasma nitroglycerin concentrations. J Pharm Sci. 1978; 67(4):582-4. DOI: 10.1002/jps.2600670445. View

Rey E, Richard M, Weber S, Bourdon A, Picard G, Olive G . Pharmacological interaction between nitroglycerin and aspirin after acute and chronic aspirin treatment of healthy subjects. Eur J Clin Pharmacol. 1983; 25(6):779-82. DOI: 10.1007/BF00542519. View

10.

Bennett B, Nakatsu K, Brien J, Marks G . Biotransformation of glyceryl trinitrate to glyceryl dinitrate by human hemoglobin. Can J Physiol Pharmacol. 1984; 62(6):704-6. DOI: 10.1139/y84-116. View

11.

Lee N . The metabolism of glyceryl trinitrate by liver and blood from different species. Biochem Pharmacol. 1973; 22(23):3122-4. DOI: 10.1016/0006-2952(73)90201-3. View

12.

Roberts R . Intravenous nitroglycerin in acute myocardial infarction. Am J Med. 1983; 74(6B):45-52. DOI: 10.1016/0002-9343(83)90854-9. View

13.

Marcus C, Habig W, Jakoby W . Glutathione transferase from human erythrocytes. Nonidentity with the enzymes from liver. Arch Biochem Biophys. 1978; 188(2):287-93. DOI: 10.1016/s0003-9861(78)80011-3. View

14.

Armstrong J, Slaughter S, Marks G, Armstrong P . Rapid disappearance of nitroglycerin following incubation with human blood. Can J Physiol Pharmacol. 1980; 58(5):459-62. DOI: 10.1139/y80-077. View

15.

Harris P, Roubin G, Sadick N, Choong C, BAUTOVICH G, Kelly D . The effect of high-dose intravenous nitroglycerin on cardiovascular hemodynamic features and left ventricular function at rest and during exercise in patients with exertional angina. Am J Cardiol. 1983; 52(2):113A-118A. DOI: 10.1016/0002-9149(83)90187-x. View

16.

DICARLO F, Melgar M . Nitroglycerin biotransformation by rat blood serum. Biochem Pharmacol. 1970; 19(4):1371-9. DOI: 10.1016/0006-2952(70)90052-3. View

17.

Heinzow B, Ziegler A . Comparison of the effects of nitroglycerin administered to rats by different routes. J Cardiovasc Pharmacol. 1981; 3(3):573-80. DOI: 10.1097/00005344-198105000-00016. View

18.

Imhof P, Sieber A, Hodler J, Muller P, Ott B, Fankhauser P . Plasma concentrations and haemodynamic effects of nitroglycerin during and after intravenous infusion in healthy volunteers. Eur J Clin Pharmacol. 1982; 23(2):99-106. DOI: 10.1007/BF00545962. View

19.

Karim A . Transdermal absorption of nitroglycerin from microseal drug delivery (MDD) system. Angiology. 1983; 34(1):11-22. DOI: 10.1177/000331978303400102. View

20.

Crouthamel W, Dorsch B . Specific high-performance liquid chromatographic assay for nitroglycerin in dosage forms. J Pharm Sci. 1979; 68(2):237-8. DOI: 10.1002/jps.2600680230. View